{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T21:40:42Z","timestamp":1772401242189,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.carrev.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T02:04:57Z","timestamp":1606961097000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device"],"prefix":"10.1016","volume":"31","author":[{"given":"Charlene L.","family":"Rohm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Gadidov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman E.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore F.","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.12.001_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCOUTCOMES.115.002359","article-title":"Decade-long trends (2001\u22122011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction","volume":"9","author":"Goldberg","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.carrev.2020.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.amjcard.2018.05.040","article-title":"Evolving concepts in diagnosis and management of cardiogenic shock","volume":"122","author":"Bellumkonda","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2019.05.032","article-title":"Utilization and outcomes of temporary mechanical circulatory support devices in cardiogenic shock","volume":"124","author":"Enezate","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjcard.2019.05.039","article-title":"Predictors of mortality and outcomes of acute severe cardiogenic shock treated with the Impella device","volume":"124","author":"Rohm","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0025","first-page":"384","article-title":"Inotropes and vasopressors use in cardiogenic shock: when, which and how much?","volume":"25","author":"Levy","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.carrev.2020.12.001_bb0030","article-title":"Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Unverzagt","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.carrev.2020.12.001_bb0035","article-title":"Vasopressors for hypotensive shock","volume":"2","author":"Gamper","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.carrev.2020.12.001_bb0040","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Schumann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.carrev.2020.12.001_bb0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00134-018-5214-9","article-title":"Management of cardiogenic shock complicating myocardial infarction","volume":"44","author":"Mebazaa","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.carrev.2020.12.001_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jacc.2018.04.052","article-title":"Norepinephrine as a first-line Inopressor in cardiogenic shock: oversimplification or best practice?","volume":"72","author":"van Diepen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0055","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2020.12.001_bb0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients [published correction appears in Intensive Care Med 2018 Nov;44(11):2022-2023]","volume":"44","author":"L\u00e9opold","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.carrev.2020.12.001_bb0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasm\u00e4ki","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.carrev.2020.12.001_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","article-title":"Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial","volume":"172","author":"Triposkiadis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.amjcard.2005.07.076","article-title":"Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction","volume":"96","author":"Jolly","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.12.001_bb0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mhj.2003.50","article-title":"Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial","volume":"145","author":"Aranda","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.12.001_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1074248418797357","article-title":"Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock","volume":"24","author":"Lewis","year":"2019","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.carrev.2020.12.001_bb0095","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.25011\/cim.v42i2.32813","article-title":"Efficacy of milrinone and dobutamine in low cardiac output states: systematic review and meta-analysis","volume":"42","author":"Mathew","year":"2019","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.carrev.2020.12.001_bb0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.carrev.2020.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2020.12.001_bb0110","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","article-title":"Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study","volume":"144","author":"Burger","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2020.12.001_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-5223(19)35469-8","article-title":"The effects of dopamine on myocardial functional recovery after reversible ischemic injury","volume":"100","author":"Kabas","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2020.12.001_bb0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.carrev.2020.12.001_bb0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.carrev.2020.12.001_bb0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock","volume":"119","author":"Basir","year":"2017","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920307843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920307843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:20:55Z","timestamp":1761560455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920307843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"alternative-id":["S1553838920307843"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.12.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}